ValuationViz

CORT fund manager activity

Corcept Therapeutics Incorporated · Nasdaq. Reported by 7 tracked fund managers in their 13F filings, Q2 2013 to Q2 2026.

Q2 2026

ManagerActivitySharesValue% of portfolioFiled
Joel Greenblatt - Gotham Asset ManagementAdded60,181$5,232,7380.01%Aug 14, 2026

Q1 2026

ManagerActivitySharesValue% of portfolioFiled
Joel Greenblatt - Gotham Asset ManagementAdded17,918$722,2750.00%May 15, 2026

Older quarters